Free Trial

TherapeuticsMD (TXMD) Stock Price, News & Analysis

TherapeuticsMD logo
$1.11 -0.01 (-0.89%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$1.10 -0.01 (-0.54%)
As of 08/29/2025 06:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About TherapeuticsMD Stock (NASDAQ:TXMD)

Key Stats

Today's Range
$1.09
$1.13
50-Day Range
$1.07
$1.22
52-Week Range
$0.70
$2.44
Volume
21,209 shs
Average Volume
16,167 shs
Market Capitalization
$12.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

TherapeuticsMD Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
13th Percentile Overall Score

TXMD MarketRank™: 

TherapeuticsMD scored higher than 13% of companies evaluated by MarketBeat, and ranked 907th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for TherapeuticsMD.

  • Percentage of Shares Shorted

    0.18% of the float of TherapeuticsMD has been sold short.
  • Short Interest Ratio / Days to Cover

    TherapeuticsMD has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in TherapeuticsMD has recently increased by 14.92%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    TherapeuticsMD does not currently pay a dividend.

  • Dividend Growth

    TherapeuticsMD does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.18% of the float of TherapeuticsMD has been sold short.
  • Short Interest Ratio / Days to Cover

    TherapeuticsMD has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in TherapeuticsMD has recently increased by 14.92%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    TherapeuticsMD has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.09 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for TherapeuticsMD this week, compared to 0 articles on an average week.
  • Search Interest

    Only 1 people have searched for TXMD on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, TherapeuticsMD insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.30% of the stock of TherapeuticsMD is held by insiders.

  • Percentage Held by Institutions

    Only 30.74% of the stock of TherapeuticsMD is held by institutions.

  • Read more about TherapeuticsMD's insider trading history.
Receive TXMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TherapeuticsMD and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TXMD Stock News Headlines

TherapeuticsMD: Q2 Earnings Snapshot
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.tc pixel
See More Headlines

TXMD Stock Analysis - Frequently Asked Questions

TherapeuticsMD's stock was trading at $0.86 at the beginning of 2025. Since then, TXMD stock has increased by 29.1% and is now trading at $1.11.

TherapeuticsMD, Inc. (NASDAQ:TXMD) announced its quarterly earnings results on Tuesday, August, 12th. The company reported $0.05 earnings per share for the quarter. The business earned $0.95 million during the quarter. TherapeuticsMD had a negative net margin of 17.94% and a negative trailing twelve-month return on equity of 2.01%.

Shares of TherapeuticsMD reverse split on Monday, May 9th 2022.The 1-50 reverse split was announced on Monday, May 9th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 9th 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of TXMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that TherapeuticsMD investors own include Voyager Therapeutics (VYGR), Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Marinus Pharmaceuticals (MRNS), AU Optronics (AUOTY) and The RMR Group (RMR).

Company Calendar

Last Earnings
8/12/2025
Today
8/31/2025
Next Earnings (Estimated)
11/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TXMD
Previous Symbol
NYSEMKT:TXMD
CIK
25743
Employees
420
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.18 million
Net Margins
-17.94%
Pretax Margin
-23.72%
Return on Equity
-2.01%
Return on Assets
-1.40%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.89
Quick Ratio
2.89

Sales & Book Value

Annual Sales
$1.76 million
Price / Sales
7.30
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.36 per share
Price / Book
0.47

Miscellaneous

Outstanding Shares
11,570,000
Free Float
11,308,000
Market Cap
$12.84 million
Optionable
Optionable
Beta
0.42

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:TXMD) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners